$3.35
0.061.82%
At close: -
$3.28
-0.07-2.09%
After Hours: Dec 20, 9:18 AM EDT
Comments
Loading...
Mereo BioPharma Group (NASDAQ:MREO) Stock, Earnings Estimates, EPS, And Revenue
Mereo BioPharma Group reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 13
EPS Estimate
$0.010
Quarterly Revenue Estimate
$14.6M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$1M
Analyze the earnings history of Mereo BioPharma Group using advanced sorting and filters.
Data brought to you by Benzinga APIs
Mereo BioPharma Group (MREO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-12 | $-0.02 | $-0.02 | 0.00 % |
Mereo BioPharma Group (MREO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?
Mereo BioPharma Group (MREO) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Mereo BioPharma Group (NASDAQ:MREO)?
The Actual EPS was $-0.02, which hit the estimate of $-0.02.
What were Mereo BioPharma Group’s (NASDAQ:MREO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.